Cargando…

Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Response to Letter]

Detalles Bibliográficos
Autores principales: Ye, JiaYi, Zhang, TianHong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544168/
https://www.ncbi.nlm.nih.gov/pubmed/37790803
http://dx.doi.org/10.2147/NDT.S439097
_version_ 1785114445872103424
author Ye, JiaYi
Zhang, TianHong
author_facet Ye, JiaYi
Zhang, TianHong
author_sort Ye, JiaYi
collection PubMed
description
format Online
Article
Text
id pubmed-10544168
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-105441682023-10-03 Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Response to Letter] Ye, JiaYi Zhang, TianHong Neuropsychiatr Dis Treat Response to Letter Dove 2023-09-28 /pmc/articles/PMC10544168/ /pubmed/37790803 http://dx.doi.org/10.2147/NDT.S439097 Text en © 2023 Ye and Zhang. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Response to Letter
Ye, JiaYi
Zhang, TianHong
Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Response to Letter]
title Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Response to Letter]
title_full Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Response to Letter]
title_fullStr Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Response to Letter]
title_full_unstemmed Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Response to Letter]
title_short Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Response to Letter]
title_sort serum levels of tumor necrosis factor-α and vascular endothelial growth factor in the subtypes of clinical high risk individuals: a prospective cohort study [response to letter]
topic Response to Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544168/
https://www.ncbi.nlm.nih.gov/pubmed/37790803
http://dx.doi.org/10.2147/NDT.S439097
work_keys_str_mv AT yejiayi serumlevelsoftumornecrosisfactoraandvascularendothelialgrowthfactorinthesubtypesofclinicalhighriskindividualsaprospectivecohortstudyresponsetoletter
AT zhangtianhong serumlevelsoftumornecrosisfactoraandvascularendothelialgrowthfactorinthesubtypesofclinicalhighriskindividualsaprospectivecohortstudyresponsetoletter